Aperture Biopharma is dedicated to helping large and small biotech companies navigate business challenges around drug pricing, payer relationships, and patient access.

Market Access

Working closely with you to develop and implement strategies that connect your products and services with your patients.


Evidence-based strategic and operational pricing expertise to support critical decisions and activities across the product lifecycle.


Leveraging deep insights and connections to deftly navigate the payer landscape, delivering access, value, and viability.


Your contracting strategy is the cornerstone of your business model, setting the tone for all of your key relationships.


The success of your product depends on getting it into the hands of the patients who need it most.


The Future of Pharma & Payer/Provider Models

The blurred line between U.S. providers and payers means Pharma needs to change how they do business.

Blockchain Basics for Pharma

What is blockchain, how it works, and opportunities for leveraging blockchain in pharma.

PBMs lowering specialty spend

Are PBMs Lowering Specialty Spend?

Coming soon.

pharmaceutical pricing affordability

Pricing to Value May Not Be Enough, Affordability Is the New Requirement for Access

Coming soon.

Aperture BioPharma Consulting Testimonials

“We loved this (affordability) concept and love that we've been able to get the expertise we've needed. Often, we get who we get and don't get the specific background and skills we need.”


Head of Payer Marketing (Leading Biotech)

“This is exactly what we needed—a deep understanding of the marketplace and the strategic agility to connect the dots. He gets it.”

Global Market Access Executive (Top 5 Pharma)

“Asif has been phenomenal. We have gotten really good insights and he has been very, very responsive while actually pushing us to get things done.”

VP, Market Access (Mid-Size Biopharma)

“Their strategic insights, cutting-edge solutions, in-depth research, and timely work reflects their personal approach to consultancy."